Business Description
Star Lake Bioscience Co Inc
NAICS : 325414
SIC : 2836
ISIN : CNE000000H46
Share Class Description:
SHSE:600866: Class ACompare
Compare
Traded in other countries / regions
600866.China IPO Date
1994-08-18Description
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.52 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.51 | |||||
| Debt-to-EBITDA | 3.05 | |||||
| Interest Coverage | 11.21 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.68 | |||||
| Beneish M-Score | -2.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 90.6 | |||||
| 3-Year EBITDA Growth Rate | 48.1 | |||||
| 3-Year EPS without NRI Growth Rate | 36.8 | |||||
| 3-Year Book Growth Rate | 26.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 22.39 | |||||
| Future 3-5Y Total Revenue Growth Rate | 2.31 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.13 | |||||
| 9-Day RSI | 46.34 | |||||
| 14-Day RSI | 49.34 | |||||
| 6-1 Month Momentum % | 19.6 | |||||
| 12-1 Month Momentum % | 43.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.15 | |||||
| Quick Ratio | 0.82 | |||||
| Cash Ratio | 0.46 | |||||
| Days Inventory | 54.25 | |||||
| Days Sales Outstanding | 15.09 | |||||
| Days Payable | 26.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.6 | |||||
| Dividend Payout Ratio | 0.61 | |||||
| Forward Dividend Yield % | 5.6 | |||||
| 5-Year Yield-on-Cost % | 5.59 | |||||
| 3-Year Average Share Buyback Ratio | -31 | |||||
| Shareholder Yield % | 9.54 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 16.26 | |||||
| Operating Margin % | 8.6 | |||||
| Net Margin % | 4.97 | |||||
| FCF Margin % | 9.45 | |||||
| ROE % | 11.43 | |||||
| ROA % | 6.01 | |||||
| ROIC % | 9.22 | |||||
| ROC (Joel Greenblatt) % | 13.6 | |||||
| ROCE % | 12.98 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.98 | |||||
| Forward PE Ratio | 9.37 | |||||
| PE Ratio without NRI | 10.9 | |||||
| Shiller PE Ratio | 84.38 | |||||
| Price-to-Owner-Earnings | 20.07 | |||||
| PEG Ratio | 0.22 | |||||
| PS Ratio | 0.63 | |||||
| PB Ratio | 1.47 | |||||
| Price-to-Tangible-Book | 1.65 | |||||
| Price-to-Free-Cash-Flow | 6.59 | |||||
| Price-to-Operating-Cash-Flow | 5 | |||||
| EV-to-EBIT | 10.47 | |||||
| EV-to-EBITDA | 10.47 | |||||
| EV-to-Revenue | 0.76 | |||||
| EV-to-FCF | 7.78 | |||||
| Price-to-Projected-FCF | 0.69 | |||||
| Price-to-Median-PS-Value | 0.2 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.44 | |||||
| Price-to-Graham-Number | 0.89 | |||||
| Earnings Yield (Greenblatt) % | 9.55 | |||||
| FCF Yield % | 14.64 | |||||
| Forward Rate of Return (Yacktman) % | 27.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Star Lake Bioscience Co Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 17,434.669 | ||
| EPS (TTM) (Â¥) | 0.52 | ||
| Beta | 0.97 | ||
| Volatility % | 45.24 | ||
| 14-Day RSI | 49.34 | ||
| 14-Day ATR (Â¥) | 0.279985 | ||
| 20-Day SMA (Â¥) | 6.9135 | ||
| 12-1 Month Momentum % | 43.63 | ||
| 52-Week Range (Â¥) | 3.35 - 8.78 | ||
| Shares Outstanding (Mil) | 1,661.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Star Lake Bioscience Co Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Star Lake Bioscience Co Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Star Lake Bioscience Co Inc Frequently Asked Questions
What is Star Lake Bioscience Co Inc(SHSE:600866)'s stock price today?
The current price of SHSE:600866 is ¥6.75. The 52 week high of SHSE:600866 is ¥8.78 and 52 week low is ¥3.35.
When is next earnings date of Star Lake Bioscience Co Inc(SHSE:600866)?
The next earnings date of Star Lake Bioscience Co Inc(SHSE:600866) is .
Does Star Lake Bioscience Co Inc(SHSE:600866) pay dividends? If so, how much?
The Dividend Yield %  of Star Lake Bioscience Co Inc(SHSE:600866) is 5.6% (As of Today), Highest Dividend Payout Ratio of Star Lake Bioscience Co Inc(SHSE:600866) was 0.61. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Star Lake Bioscience Co Inc(SHSE:600866) is 5.6%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers